Aytu expands reach into ADHD Therapeutic Market. Learn more Good health starts early. Aytu pediatric medicines. Learn more A family of innovative products that’s perfect for yours. Learn more Aytu to sponsor the upcoming PREVEnt Trial to evaluate the effectiveness of AR101 (enzastaurin) in patients with VEDS. Learn more See the light. Healight study for COVID-19. Learn more ADHD affects people of all ages and all stages of life. Learn more Aytu announces formation of new Scientific Advisory Board to support development of AR101 for VEDS. Learn more Contact Us Thanks for contacting us! We will get in touch with you shortly.